AUG 15, 2018 12:27 AM PDT

Peripheral Nerve Blockers Treat Facial Pain

WRITTEN BY: Nouran Amin

A new research study published in the American Journal of Emergency Medicine explains the use of peripheral nerve inhibitors in the treatment of facial pain condition known as Trigeminal Neuralgia (TGN). TGN involves sudden episodes of severe facial pain that can significantly reduce the quality of life for affected individuals.

Some patients seek highly precise invasive procedures when proper medication fails to manage the pain. However, invasive procedures often leave patients with discomfort and the long period of numbness. Fortunately, the study examined alternatives that can give patients promising results with less discomfort. Such an alternative is Peripheral Trigeminal Nerve Blocks (PTNB). PTNB can be thought of as another procedure in which a numbing medication is administered through an injection at the site where the problem nerve reaches the facial pain area. Although PTNB serves as a promising alternative, the efficacy of this particular drug has not been well studied in both short-term and long-term management of TGN.

Image Retrieved From Unsplash, www.unsplash.com

During a case series in the American Journal of Emergency Medicine, Michael Perloff, MD, a clinical neurologist and an assistant professor of neurology at Boston University School of Medicine, examined nine TGN patients that were treated with PTNB. Perloff found that all nine patients had an immediate relief of their pain after the administered procedure, with many reporting pain-free feeling. Additionally, six of these nine patients reported continued pain relief from a range of one to eight months that followed the procedure, with two of the patients experiencing a complete resolution of their pain months after the administered injections. Perloff believes these results to be an encouraging step towards effective pain management for patients with TGN. "PTNB can be a simple, safe alternative compared to opioids, invasive ganglion level procedures or surgery."

Source: Boston University School of Medicine

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Drug Regimen Improves Clinical Outcomes for Kidney Transplant Patients
Recent preliminary clinical trial results indicate the immunosuppressive drug belatacept can safely and effectively treat kidney transplant patients withou...
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Tart Cherry and Pain Management in Breast Cancer Patients
In patients with non-metastatic breast cancer, treated with aromatase inhibitors, tart cherry was found to reduce the musculoskeletal effects of the drug. ...
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Breakthrough Synthesis Advances Potent Anti-Cancer Agent
What is now known as a "landmark in drug discovery", Harvard chemists have succeeded in synthesizing halichondrin, found naturally in sea sponges...
SEP 16, 2019
Cell & Molecular Biology
SEP 16, 2019
Progress on a Potential Drug for Inflammatory Disease
A team of researchers is trying to develop a treatment for chronic inflammatory disorders by inhibiting a complex called the NLRP3 inflammasome....
SEP 16, 2019
Cell & Molecular Biology
SEP 16, 2019
How the Kava Plant Creates Medicinal Compounds
Nature has given us some of our best medicines; it's thought that as many as half the drugs we used are derived from natural products....
SEP 16, 2019
Immunology
SEP 16, 2019
A New Way To Fight Severe Peanut Allergies
Dr. Sandra Lin explains how SLIT is currently being used to treat allergies other than peanuts.    Over 1 million U.S. children have an allergy t...
Loading Comments...